Skip to main content
. 2018 Apr 24;8(6):773–778. doi: 10.3892/mco.2018.1616

Table III.

Demographic data of patients with cT1 upper third gastric cancer.

Correct group (n=27) Underestimated group (n=10) P-value
Age (years) 71.4±9.4 71.9±7.6 0.932
Male/female 21/6 8/2 0.884
Body mass index 22.5±2.8 22.3±2.2 0.871
Tumor size (mm) 32.7±24.1 44.8±34.5 0.266
Tumor size, mm
  >=20 17 (63.0%) 9 (90.0%) 0.110
  <20 10 (37.0%) 1 (10.0%)
Operation
  Total gastrectomy 11 (40.7%) 4 (40.0%) 0.968
  Proximal gastrectomy 16 (59.3%) 6 (60.0%)
Circumferences
  Ant/post 6/9 0/6 0.067
  Gre/less 3/18 3/5 0.168
Lymph nodal metastasis
  cN0 26 (96.3%) 10 (100%) 0.537
  cN1 1 (2.7%) 0 (0%)
Gross type
  Elevated 11 (40.7%) 2 (40.0%) 0.714
  Flat 3 (11.1%) 0 (0%)
  Depressed 13 (48.2%) 3 (60.0%)
Histology
  Intestinal type 25 (92.6%) 6 (60.0%) 0.017
  Diffuse type 2 (7.4%) 4 (40.0%)
Stroma
  Int 13 (86.7%) 5 (50.0%) 0.028
  Med 2 (13.3%) 1 (10.0%)
  Sci 0 (0%) 4 (40.0%)
Infiltrative growth
  a 0 (0%) 0 (0%) 0.002
  b 15 (69.6%) 5 (50.0%)
  c 0 (0%) 5 (50.0%)
Lymphatic invasion
  ly (−) 19 (70.4%) 2 (20.0%) 0.010
  ly (+) 8 (29.6%) 8 (80.0%)
Venous invasion
  v (−) 18 (66.7%) 1 (10.0%) 0.003
  v (+) 9 (33.3%) 9 (90.0%)